← Open Payments lookup

SARAH REYNOLDS: Open Payments

NPI 1851722615 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 14 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $174 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.1$103
BioCryst US Sales Co., LLC3$66
GENZYME CORPORATION2$59
Novartis Pharmaceuticals Corporation1$30
AstraZeneca Pharmaceuticals LP1$28
GlaxoSmithKline, LLC.1$25
Blueprint Medicines Corporation1$24
Optinose US, Inc.1$21
Boston Scientific Corporation1$21
Regeneron Healthcare Solutions, Inc.1$20

Products named: DUPIXENT, ORLADEYO, XOLAIR, FASENRA, NUCALA, AYVAKIT, Xhance, General - Pain Management.

Industry payments across CO — which companies pay providers there.